ClinicalTrialsFinder

Metastatic Breast Cancer Clinical Trials in Ciudad Autónoma de Buenos Aires, Buenos Aires

1 recruitingCiudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

Metastatic Breast Cancer
Merck Sharp & Dohme LLC120 enrolled41 locationsNCT06428396